“Exploring the Potential of Rivaroxaban in Children With Cancer: Advantages over Standard Anticoagulants”. Voprosy Onkologii, vol. 69, no. 3, June 2023, pp. 399-05, https://doi.org/10.37469/0507-3758-2023-69-3-399-405.